Temporal Profiles of Symptom Scores After Palliative Radiotherapy for Bleeding Gastric Cancer With Adjustment for the Palliative Prognostic Index: An Exploratory Analysis of a Multicentre Prospective Observational Study (JROSG 17–3)
Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7
A commentary on key methodological developments related to nutritional life cycle assessment (nLCA) generated throughout a 6‐year strategic scientific programme.
We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.